Fluoxetine in Pediatric Body Dysmorphic Disorder

Completed · Phase 4 · Has a placebo group

Conditions studied: Body Dysmorphic Disorder

In brief

This trial will study the effectiveness of the medication fluoxetine for children and adolescents ages 16 and younger with BDD who qualify.

Key facts

Study ID

NCT00245635

Run by

Montefiore Medical Center

People needed

43

Starts

2004-11-01

Expected to finish

2012-04-01

Last updated by the study team

2018-04-27

Who can join

Age: any, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female children and adolescents aged 16 and younger
• BDD or its delusional variant present currently and for at least 6 months prior to the study
• Ability to communicate meaningfully with the investigators and competent to provide written assent

You may not qualify if…

• Presence of Schizophrenia or Bipolar Disorder
• Recent suicide attempt or suicidal ideations that warrant hospitalizations
• Previous allergic reaction to fluoxetine
• History of a seizure disorder

Where it is running

• Montefiore Medical Center, Albert Einstein College of Medicine — The Bronx, New York, United States
• Rhode Island Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.